- 专利标题： Methods for the prevention and treatment of hearing loss using Oseltamivir
-
申请号： US18129267申请日： 2023-03-31
-
公开(公告)号： US12053446B1公开(公告)日： 2024-08-06
- 发明人: Tal Teitz , Jian Zuo , Taosheng Chen
- 申请人： Ting Therapeutics LLC
- 申请人地址： US NE Omaha
- 专利权人： Ting Therapeutics LLC,St Jude Children's Research Hospital
- 当前专利权人： Ting Therapeutics LLC,St Jude Children's Research Hospital
- 当前专利权人地址： US NE Omaha; US TN Memphis
- 代理机构： Veritay Group IP PLLC
- 代理商 Susan Fentress
- 主分类号： A61K31/196
- IPC分类号： A61K31/196 ; A61K31/282 ; A61K31/7028 ; A61P27/16
摘要：
Oseltamivir is used as active agent to treat a hearing impairment and to prevent a hearing impairment, and a method of treating and/or preventing hearing impairments or disorders using Oseltamivir are disclosed. Oseltamivir exhibits excellent protection against noise-induced hearing loss and against cisplatin-induced hearing loss.
信息查询
IPC分类:
